Physician profile
Jennifer S Mcdonnell
NPI 1952470726
$2,264.64
in general payments reported to CMS, 2019-2025
25 companies · $531 in 2025
The $531 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.60 · 2022: $328 · 2023: $721 · 2024: $656 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,908.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $493.66 | 2021-2025 | Entyvio, Livtencity, Gattex |
| Abbvie INC. | $269.76 | 2021-2025 | |
| Janssen Biotech, INC. | $255.33 | 2022-2025 | Tremfya, Stelara, Simponi Aria |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $182.04 | 2022-2024 | Trulance, Xifaxan |
| Celgene Corporation | $122.20 | 2022-2024 | Zeposia |
| Regeneron Healthcare Solutions, INC. | $117.15 | 2023-2024 | Dupixent |
| Intercept Pharmaceuticals, INC. | $102.84 | 2022-2025 | |
| Ferring Pharmaceuticals INC. | $89.59 | 2023-2025 | Rebyota |
| Qol Medical, LLC | $80.78 | 2023-2025 | Sucraid |
| Genzyme Corporation | $62.93 | 2022-2024 | |
| Orphalan INC | $56.31 | 2024-2025 | Cuvrior |
| Ardelyx, INC. | $48.13 | 2022-2023 | Ibsrela |
| Gilead Sciences, INC. | $42.02 | 2025 | |
| Madrigal Pharmaceuticals | $41.22 | 2025 | Rezdiffra |
| Fujifilm Healthcare Americas Corporation | $36.27 | 2024 | Utaswako Afp-L3 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $34.24 | 2025 | Zenpep |
| Nestle Healthcare Nutrition INC. | $33.86 | 2022-2023 | |
| Exact Sciences Corporation | $28.17 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $26.20 | 2025 | Omvoh |
| Mallinckrodt Hospital Products INC. | $25.05 | 2024 | Terlivaz |
| Pentax of America, INC. | $25.02 | 2024 | Pentax Medical, C2 Cryoballoon, Inspira |
| Braintree Laboratories, INC. | $24.69 | 2024 | Suflave, Sutab |
| Ironwood Pharmaceuticals, INC | $24.13 | 2023 | Linzess |
| Evoke Pharma, INC. | $22.23 | 2023 | Gimoti |
| Phathom Pharmaceuticals, INC. | $20.82 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Mcdonnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.